1

Epratuzumab: A Deep Dive into the CD22 Antibody Treatment

News Discuss 
This agent is the novel monoclonal specific to CD22, the surface protein present largely on Lymphoid lymphocytes . This process of effect involves blocking CD22-mediated signaling , consequently https://amg41668679.wikiannouncement.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story